Binding of rapamycin analogs to calcium channels and FKBP52 contributes to their neuroprotective activities

Abstract

Rapamycin is an immunosuppressive immunophilin ligand reported as having neurotrophic activity. We show that modification of rapamycin at the mammalian target of rapamycin (mTOR) binding region yields immunophilin ligands, WYE-592 and ILS-920, with potent neurotrophic activities in cortical neuronal cultures, efficacy in a rodent model for ischemic stroke, and significantly reduced immunosuppressive activity. Surprisingly, both compounds showed higher binding selectivity for FKBP52 versus FKBP12, in contrast to previously reported immunophilin ligands. Affinity purification revealed two key binding proteins, the immunophilin FKBP52 and the β1-subunit of L-type voltage-dependent Ca²⁺ channels (CACNB1). Electrophysiological analysis indicated that both compounds can inhibit L-type Ca²⁺ channels in rat hippocampal neurons and F-11 dorsal root ganglia (DRG)/neuroblastoma cells. We propose that these immunophilin ligands can protect neurons from Ca²⁺-induced cell death by modulating Ca²⁺ channels and promote neurite outgrowth via FKBP52 binding.

• immunophilin
• L-type voltage-gated calcium channel
• natural products
• neurodegeneration
• stroke